275 related articles for article (PubMed ID: 3038447)
1. Myocardial infarct imaging in patients with technetium-99m 2,3-dimercaptosuccinic acid. Superiority of technetium-99m pyrophosphate.
Lyons KP; Milne N; Karlsberg RP; Olson HG; Kuperus J
Clin Nucl Med; 1987 Jul; 12(7):514-8. PubMed ID: 3038447
[TBL] [Abstract][Full Text] [Related]
2. Imaging of experimental myocardial infarction with technetium-99m 2,3-dimercaptosuccinic acid.
Karlsberg RP; Milne N; Lyons KP; Aronow WS
J Nucl Med; 1981 Mar; 22(3):253-7. PubMed ID: 6259303
[TBL] [Abstract][Full Text] [Related]
3. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the tumor-seeking agent Tc-99m(V) dimercaptosuccinic acid and the renal imaging agent Tc-99m dimercaptosuccinic acid in humans.
Ohta H; Ishii M; Yoshizumi M; Endo K; Sakahara H; Nakajima T; Yomoda I; Masuda H; Horiuchi K; Hata N
Clin Nucl Med; 1985 Mar; 10(3):167-70. PubMed ID: 2985320
[TBL] [Abstract][Full Text] [Related]
5. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
[TBL] [Abstract][Full Text] [Related]
6. Early positive technetium-99m stannous pyrophosphate images as a marker of reperfusion after thrombolytic therapy for acute myocardial infarction.
Wheelan K; Wolfe C; Corbett J; Rude RE; Winniford M; Parkey RW; Buja LM; Willerson JT
Am J Cardiol; 1985 Aug; 56(4):252-6. PubMed ID: 4025161
[TBL] [Abstract][Full Text] [Related]
7. Images of liposarcoma using technetium-99m bleomycin and technetium (V)-99m DMSA.
Ohta H; Shane FI; Endo K; Torizuka K; Horiuchi K; Yokoyama A; Ishii M
Clin Nucl Med; 1986 Dec; 11(12):842-4. PubMed ID: 2434276
[TBL] [Abstract][Full Text] [Related]
8. Scintigraphic detection of experimental myocardial infarction with 99mTc-2,3-dimercaptosuccinic acid.
Duska F; Novák J; Mazurová Y; Kubícek J; Vizd'a J; Kafka P; Veverková O
Nuklearmedizin; 1984 Dec; 23(6):317-9. PubMed ID: 6099542
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of coronary reperfusion for acute myocardial infarction by emission CT using technetium-99m pyrophosphate].
Hashimoto T; Kambara H; Nohara R; Fudo T; Uozu K; Tamaki S; Kawai C
J Cardiol; 1987 Jun; 17(2):231-9. PubMed ID: 2966242
[TBL] [Abstract][Full Text] [Related]
10. False-positive technetium-99m DMSA renal imaging in two cases of malrotated kidney.
Ueno K; Rikimaru S; Miyagi T; Mohri S
Clin Nucl Med; 1985 Jul; 10(7):504-6. PubMed ID: 2992862
[TBL] [Abstract][Full Text] [Related]
11. Comparison of indium-111 antimyosin antibody and technetium-99m pyrophosphate localization in reperfused and nonreperfused myocardial infarction.
Takeda K; LaFrance ND; Weisman HF; Wagner HN; Becker LC
J Am Coll Cardiol; 1991 Feb; 17(2):519-26. PubMed ID: 1846888
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Tc-99m pyrophosphate and Tc-99m methylene diphosphonate in acute myocardial infarction: concise communication.
Kelly RJ; Chilton H; Hackshaw BT; Ball JD; Watson NE; Kahl FR; Cowan FJ
J Nucl Med; 1979 May; 20(5):402-6. PubMed ID: 232147
[TBL] [Abstract][Full Text] [Related]
13. A comparison of infarct identification with technetium-99m pyrophosphate and staining with triphenyl tetrazolium chloride.
Izquierdo C; Devous MD; Nicod P; Buja LM; Parkey RW; Bonte FJ; Willerson JT; Lewis SE
J Nucl Med; 1983 Jun; 24(6):492-7. PubMed ID: 6304264
[TBL] [Abstract][Full Text] [Related]
14. Imaging of head and neck tumors with technetium(V)-99m DMSA. A new tumor-seeking agent.
Ohta H; Endo K; Fujita T; Nakashima T; Sakahara H; Torizuka K; Shimizu Y; Ishii Y; Makimoto K; Hata N
Clin Nucl Med; 1985 Dec; 10(12):855-60. PubMed ID: 3000682
[TBL] [Abstract][Full Text] [Related]
15. Comparison of left ventricular function and infarct size in patients with and without persistently positive technetium-99m pyrophosphate myocardial scintigrams after myocardial infarction: analysis of 357 patients.
Croft CH; Rude RE; Lewis SE; Parkey RW; Poole WK; Parker C; Fox N; Roberts R; Strauss HW; Thomas LJ
Am J Cardiol; 1984 Feb; 53(4):421-8. PubMed ID: 6320623
[TBL] [Abstract][Full Text] [Related]
16. Acute myocardial infarction delineated by noninvasive thallium-201/technetium-99m pyrophosphate tomography.
Krause T; Joseph A; Kutzner C; Kasper W; Schuemichen C; Just H; Moser E
Nucl Med Commun; 1990 Sep; 11(9):617-29. PubMed ID: 2172880
[TBL] [Abstract][Full Text] [Related]
17. Analogy between tumor uptake of technetium(V)-99m dimercaptosuccinic acid (DMSA) and technetium-99m-MDP.
Wulfrank DA; Schelstraete KH; Small F; Fallais CJ
Clin Nucl Med; 1989 Aug; 14(8):588-93. PubMed ID: 2553315
[TBL] [Abstract][Full Text] [Related]
18. [Scintigraphic detection of acute experimental myocardial infarct in dogs using 99m-2,3-dimercaptosuccinate].
Duska F; Kubícek J; Novák J; Kafka P; Vizda J; Mazurová Y
Cas Lek Cesk; 1984 Dec; 123(52):1590-4. PubMed ID: 6097358
[No Abstract] [Full Text] [Related]
19. Comparison of technetium-99m pyrophosphate and technetium-99m methylene diphosphonate with variable amounts of stannous chloride in the detection of acute myocardial infarction.
Huckell VF; Lyster DM; Morrison RT; Cooper JA
Clin Nucl Med; 1985 Jul; 10(7):455-62. PubMed ID: 4028596
[TBL] [Abstract][Full Text] [Related]
20. Indium-111-antimyosin antibody imaging for detecting different stages of myocardial infarction: comparison with technetium-99m-pyrophosphate imaging.
Tamaki N; Yamada T; Matsumori A; Yoshida A; Fujita T; Ohtani H; Watanabe Y; Yonekura Y; Endo K; Konishi J
J Nucl Med; 1990 Feb; 31(2):136-42. PubMed ID: 2156026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
